91丨九色丨白浆丨老牛,午夜成人免费视频,精品人妻无码一区二区三区淑枝,91精品久久香蕉国产国二厂线看,少妇精品无码一区二区三区大长今

Alzheimer’s disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling

Release time: Publisher:MKT Dept Reading times:


【PUBLIC SUMMARY】:

- In-depth proteomics workflow for profiling paired cerebrospinal fluid (CSF) and serum proteomes.
- Independent multicenter set combined with multiple methods for validation.
- Development of 19 CSF- and 8 serum-protein panels for early of Alzheimer disease (AD) diagnosis.
- Twenty-one CSF and 18 serum proteins dysregulated in different AD stages.
- Groundwork laid for AD blood tests in clinical screening and staging.


Amyloid-β, tau pathology, and biomarkers of neurodegeneration make up the core diagnostic biomarkers of Alzheimer disease (AD). However, these proteins represent only a fraction of the complex biological processes underlying AD, and individuals with other brain diseases in which AD pathology is a comorbidity also test positive for these diagnostic biomarkers. More AD-specific early diagnostic and disease staging biomarkers are needed. In this study, we performed tandem mass tag proteomic analysis of paired cerebrospinal fluid (CSF) and serum samples in a discovery cohort comprising 98 participants. Candidate biomarkers were validated by parallel reaction monitoring–based targeted proteomic assays in an independent multicenter cohort comprising 288 participants. We quantified 3,238 CSF and 1,702 serum proteins in the discovery cohort, identifying 171 and 860 CSF proteins and 37 and 323 serum proteins as potential early diagnostic and staging biomarkers, respectively. In the validation cohort, 58 and 21 CSF proteins, as well as 12 and 18 serum proteins, were verified as early diagnostic and staging biomarkers, respectively. Separate 19-protein CSF and an 8-protein serum biomarker panels were built by machine learning to accurately classify mild cognitive impairment (MCI) due to AD from normal cognition with areas under the curve of 0.984 and 0.881, respectively. The 19-protein CSF biomarker panel also effectively discriminated patients with MCI due to AD from patients with other neurodegenerative diseases. Moreover, we identified 21 CSF and 18 serum stage-associated proteins reflecting AD stages. Our findings provide a foundation for developing blood-based tests for AD screening and staging in clinical practice.



【Blood biomarker assessment】: Serum GFAP and NEFL were quantified by commercially available Single Molecular Immunity Detection kits (Astrabio, R14060 and R14040). All of the measurements were conducted on an AST-Sc-Lite analyzer (Astrabio) and were performed according to the manufacturer’s instructions.



DOI https://doi.org/10.1016/j.xinn.2023.100544

97人妻精品一区二区三区动漫 | 曰本A片色情观看Mv 一本无码人妻一区二区 | 丰满少妇猛烈进入无码 | 2021人人操人人爱 | 俄罗斯18无码精品一区 | 无码精品人妻一区二区三区影院 | 精品无码视频在线免费观看 | 天美传媒妇乱XXXXX | 寡妇免费A片一级无极看 | 大陆搡BBBBB搡BBBBBB | 亚洲毛片高清无码在线观看 | 国产一级a毛一级a | 国产黄色在线观看视频 | 红桃视频一区二区高清码 | 永久免费看mv网站入口亚洲 | 国产精品羞羞无码久久久 | 日本一级婬片A片AAA免费 | 精品国产一级黄色片网站 | 手机在线不卡无码操三八 | AV网站在线免费观看 | 亚洲熟妇色XXXX凹凸一区 | 精品动漫3D一区二区三区 | 亚欧精美大片精品精选 | 西西4444WWW大胆无视频 | 精产品99永久免费网页版 | 亚洲熟女少妇在线观看 | 加勒比无码Av朝桐光 | 色噜噜狠狠一区二区三区牛牛影视 | 国产精品JIZZ在线观看99 | 91精品在线免费视频 | 久久久精品人妻一区二区三区蜜芽 | 精品少妇高潮乱码久久久久 | 一本大道东京热av无码 | 国产精品午夜未成人免费观看 | 亚洲一二三区在线观看 | AV鲁丝一区鲁丝二区鲁丝四区 | 嫩BBB揉BBBB揉BBBB | 欧美一区二区不卡视频 | 粉嫩av无码一区二区三区四区五区 | 18禁网站在现观看 | 丰满少妇一 A片免费 |